Pasar al contenido principal

OPTIMIZACION DE UNA PLATAFORMA DE VECTORES NO VIRALES BASADOS EN NIOSOMAS FUNCIONALIZADOS CON NANODIAMANTES PARA TERAPIA GENICA EN FIBROSIS QUISTICA

PRE2020-092307

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Formación
Convocatoria Contratos Predoctorales
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DEL PAIS VASCO EUSKAL HERRIKO UNIBERTSITATEA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A novel gene delivery approach to face cystic fibrosis by non-viral vectors based on niocarbosomes

  • Maldonado, Iván
  • Gallego, Idoia
  • Enriquez-Rodriguez, Lucia
  • Iturrospe, Amaia
  • Arbe, Arantxa
  • Mashal, Mohamed
  • Attia, Noha
  • Puras, Gustavo
  • Pedraz, José Luis
Non-viral vectors are a promising approach to address genetic-based diseases, such as cystic fibrosis (CF), due to their safety profile and lower production costs compared to viral vectors. This study includes the development of conventional niosomes using the oil-in-water (o/w) emulsion technique, which were based on 2,3-di(tetradecyloxy)propan-1-amine (DTPA) cationic lipid and polysorbate 85 as a non-ionic surfactant. Additionally, novel niosomes referred to as niocarbosomes were developed incorporating carboxyl-functionalised single-walled carbon nanotubes (SWNT-COOH) as a helper component. The physicochemical properties of formulations and their complexes obtained upon the addition of genetic material, referred to as nioplexes and niocarboplexes respectively, were thoroughly examined using transmission electron microscopy (TEM), dynamic light scattering (DLS), and small-angle X-ray scattering (SAXS) techniques. Furthermore, the formation of protein corona around the non-viral vectors was investigated upon exposure to human blood plasma. Niocarbosomes complexed with pEGFP reporter gene transfected around 26% of treated cells mainly via the lipid rafts pathway, with a cell viability rate of 85%. Next, these niocarbosomes were complexed with a therapeutic plasmid coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein (pGM169) for CF treatment. Treated cells showed a 65% increase in CFTR functionality compared to untreated cells, demonstrating the potential of niocarbosome non-viral gene delivery systems to face CF disease., This work was supported by the Basque Country Government (Consolidated Groups, IT1448-22). Authors also wish to thank the intellectual and technical assistance from the ICTS “NANBIOSIS,” more specifically by the Drug Formulation Unit (U10) of the CIBER in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN) at the University of the Basque Country (UPV/EHU). I.M. thanks the Spanish Ministry of science and innovation (Grant PID2019-106199RB-C21) predoctoral grant PRE2020-092307. L.E.R. thanks the Basque Country Government for the granted pre-doctoral fellowship (PRE_2022_1_0042). N.A. and M.M acknowledge the Spanish Ministry of Universities and the European Union-Next Generation EU for the Margarita Salas grant (MARSA21/98 and MARSA21/97, respectively) at the University of the Basque Country (UPV/EHU). A. I. and A. A. acknowledge the Grant PID2021-123438NB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”, Grant TED2021-130107A-I00 funded by MCIN/AEI/10.13039/501100011033 and Unión Europea “NextGenerationEU/PRTR”, This work benefited from the use of the SasView application, originally developed under NSF award DMR-0520547., SasView contains code developed with funding from the European Union’s Horizon 2020 research and innovation programme under the SINE2020 project, grant agreement No 654000., Peer reviewed